No association between BDNFVal66Met polymorphism and treatment response in obsessive-compulsive disorder in the Japanese population

por Umehara H, Numata S, Kinoshita M, Watanabe S, Nakaaki S, Sumitani S, Ohmori T
Publicado 2016

Gene expression-based biological test for major depressive disorder: an advanced study

por Watanabe S, Numata S, Iga J, Kinoshita M, Umehara H, Ishii K, Ohmori T
Publicado 2017

Elevated peripheral blood glutamate levels in major depressive disorder

por Inoshita M, Umehara H, Watanabe S, Nakataki M, Kinoshita M, Tomioka Y, Tajima A, Numata S, Ohmori T
Publicado 2018

Negative and positive self-thoughts predict subjective quality of life in people with schizophrenia

por Takeda T, Nakataki M, Ohta M, Hamatani S, Matsuura K, Yoshida R, Kameoka N, Tominaga T, Umehara H, Kinoshita M, Watanabe S, Numata S, Sumitani S, Ohmori T
Publicado 2019

Structural equation modeling approach between salience network dysfunction, depressed mood, and subjective quality of life in schizophrenia: an ICA resting-state fMRI study

por Ohta M, Nakataki M, Takeda T, Numata S, Tominaga T, Kameoka N, Kubo H, Kinoshita M, Matsuura K, Otomo M, Takeichi N, Harada M, Ohmori T
Publicado 2018